Latest Shareholder Support News

ARCH Emerging Markets Partners, Evolution Energy Minerals’ largest shareholder, confirms it will fully subscribe to the company’s renounceable rights issue, supporting a $1.45 million capital raise.

Mount Ridley Mines has announced a capital raising of up to $830,388 through a placement and a pro-rata rights issue, aiming to fund ongoing projects and explore new mining opportunities.

Dundee Precious Metals Inc. shareholders have overwhelmingly approved a key resolution and a corporate name change, clearing a major hurdle in their recommended acquisition of Adriatic Metals Plc. This milestone sets the stage for the final court sanction and subsequent integration steps.

Bailador Technology Investments reported a solid $19.3 million net profit for FY25, declared a fully-franked dividend yielding 8.1% grossed-up, and deployed $40.8 million into expanding its fast-growing tech portfolio.

Atomo Diagnostics has successfully placed $416,611.77 from its Share Purchase Plan shortfall, bolstered by a recent US order from Lumos Diagnostics. This capital injection strengthens Atomo’s position as it scales up production of its Pascal cassettes.

ikeGPS has dramatically exceeded its $2 million target in a recent share purchase plan, raising over $8 million to fuel its growth ambitions. The strong shareholder backing underscores confidence in the company’s strategic direction.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

Sayona Mining’s merger with Piedmont Lithium faces further delay due to shareholder quorum shortfall, prompting an extension of its financing agreement with Resource Capital Fund VIII. The extension includes a potential AU$38 million capital injection through new options.

Platinum Capital Limited has withdrawn its proposed scheme of arrangement due to insufficient shareholder support and is now seeking approval for an on-market buy-back of up to 50% of its shares, aiming to enhance liquidity for investors.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.

X2M Connect Limited has completed a $309,000 entitlement offer by issuing 23.76 million new shares and options, while a substantial shortfall of nearly 127 million shares remains available for placement.

Platinum Capital Limited has pulled its proposed scheme of arrangement due to insufficient shareholder support but will proceed with an on-market buy-back. Meanwhile, L1 Capital pushes for management control and board renewal.